Less Ads, More Data, More Tools Register for FREE

TechMark movers: Consort Medical jumps on acquisition

Thu, 24th Sep 2009 17:02
Drug inhaler firm Consort Medical has agreed a recommended cash offer of approximately £16.5m for rival The Medical House.Medical House shareholders will receive 27.5p in cash for each share, which is a 93% premium to the closing price of The Medical House on 11 August - the last dealing day prior to the group announcing it had received an offer. A full Loan Notes alternative will also be available.Consort Medical said the acquisition of The Medical House as an attractive opportunity to enhance its existing position as a leading global supplier of drug delivery device and airway management product technologies. FTSE TechMARK - RisersOxford Biomedica (OXB) 12.00p +11.63%Alphameric (ALM) 36.50p +9.77%Kofax (KFX) 160.00p +8.84%Emblaze (BLZ) 42.50p +8.28%Consort Medical (CSRT) 430.00p +8.18%Innovation Group (TIG) 12.00p +6.67%Kewill (KWL) 102.00p +4.35%Antisoma (ASM) 35.75p +2.88%Alterian (ALN) 171.75p +2.23%Phoenix IT Group (PNX) 226.00p +2.03%FTSE TechMARK - FallersDialight (DIA) 162.00p -4.71%Morse (MOR) 33.50p -3.60%Wolfson Microelectronics (WLF) 141.50p -3.08%Oxford Instruments (OXIG) 190.50p -2.56%NXT (NTX) 10.50p -2.33%Asterand (ATD) 23.75p -2.06%Sepura (SEPU) 49.50p -1.98%AEA Technology (AAT) 30.25p -1.63%SDL International (SDL) 370.00p -1.60%Puricore (PURI) 17.25p -1.43%

Shares in this article

Related News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Burberry + 13 more shares
Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional